Insights into Anti-metastatic therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, inhibits VEGF expression via up regulation of its target miRNA, 30/December/2013, 6.55 am

Insights into Anti-metastatic therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, inhibits VEGF expression via up regulation of its target miRNA, 30/December/2013, 6.55 am

Insights into Anti-metastatic therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, inhibits VEGF expression via up regulation of its target miRNA, 30/December/2013, 6.55 am 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

To citeBoominathan, Insights into Anti-metastatic therapy: Epigallocatechin 3-Gallate (EGCG), the major component of Green tea, inhibits VEGF expression via up regulation of its target miRNA, 30/December/2013, 6.55 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/